Transfection of human insulin-like growth factor-binding protein 3 gene inhibits cell growth and tumorigenicity: A cell culture model for lung cancer

Journal of Endocrinology

Volumn 166, Issue 3, 2000, Pages 553-563

  Hochscheid, R ^a   Jaques, G ^a   Wegmann, B ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOGENICITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG CANCER; LUNG CARCINOGENESIS; PRIORITY JOURNAL;

EID: 0033830418     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1660553     Document Type: Article

References (36)

1. Characterization of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex
2. Binding proteins for the insulin-like growth factors: Structure, regulation and function
3. Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation
4. Induction of the growth inhibitor IGF-binding protein 3 by p53
5. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in human breast carcinoma cell line
6. Transfection of the human insulin-like growth factor binding protein-3 gene into Balb/c fibroblasts inhibits cellular growth
7. Structural and biological characterization of bovine insulin-like growth factor binding protein-3
8. Overexpression of an inhibitory insulin-like growth factor binding protein (IGFBP), IGFBP-4, delays onset of prostate tumor formation
9. The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors
10. An insulin-like growth factor (IGF) binding protein enhances the biological response to IGF-1
11. Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency
12. Advances in the biology of non small cell lung cancer
13. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta 2-induced growth inhibition in human breast cancer cells
14. Analysis of serum insulin-like growth factor binding proteins using Western blotting. Use of the method for titration of the binding proteins and competitive binding studies
15. Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells
16. Production of immunoreactive insulin-like growth factor-1 and response to exogenous IGF-I in small cell lung cancer cell lines
17. Differential expression of insulin-like growth factor binding proteins in human non-small cell lung cancer cell lines
18. Nuclear localization of insulin-like growth factor binding protein 3 in a lung cancer cell line
19. Insulin-like growth factor binding protein expression in human small cell lung cancer cell lines
20. Direct demonstration of separate receptors for growth activities of insulin and multiplication-stimulating activity (an insulin-like growth factor) using antibodies to the insulin receptor
21. Monoclonal antibodies to receptors for insulin and somatomedin-C
22. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin
23. The type V transforming growth factor beta receptor is the putative insulin-like growth factor-binding protein 3 receptor
24. p53 gene mutations in small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features
25. Growth factor effects on small cell lung cancer cells using a colorimetric assay: Can a transferrin-like factor mediate autocrine growth?
26. Insulin-like growth factors stimulate the release of insulin-like growth factor-binding protein-3 (IGFBP-3) and degradation of IGFBP-4 in nonsmall cell lung cancer cell lines
27. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells
28. Transforming growth factor-β-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action
29. Insulin-like growth factor-binding protein-3 (IGF-BP3) inhibits estrogen-stimulated breast cancer cell proliferation
30. Nuclear localization signal in insulin-like growth factor-binding protein type 3
31. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism
32. Expression of insulin-like growth factor (IGF) and IGF-binding protein genes in human lung tumor cell lines
33. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6)
34. Anabolic effects of insulin-like growth factor-I (IGF-I) and an IGF-I variant in normal female rats
35. Molecular cloning of IGFBP-5 from SCLC cell lines and expression of IGFBP-4, IGFBP-5 and IGFBP-6 in lung cancer cell lines and primary tumors
36. Intranuclear localization of insulin-like growth factor binding protein-3 (IGFBP-3) during cell division in human keratinocytes